// App-Quantinova.ai

EP371 : INOTUZUMAB OZOGAMICIN IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA: A REAL-WORLD RETROSPECTIVE STUDY IN THE UK

Researchers

Presenter

  • David Marks

Principal Investigators

  • Myriam Alexander

  • Joe Eva

  • Simon Purcell

  • Sam Wood

Medical Centers

  • Real-World Evidence,Open Health Communications LLP,Marlow,United Kingdom

  • Global Pfizer Oncology,Pfizer Ltd.,Surrey,United Kingdom

  • Global Pfizer Oncology,Pfizer Ltd.,Surrey,United Kingdom

  • Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Inotuzumab ozogamicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved